Adenosquamous carcinoma of the head and neck: Criteria for diagnosis in a study of 12 cases

Histopathology

Volumn 44, Issue 6, 2004, Pages 570-579

  Alos, L ^a,b   Castillo, M ^a   Nadal, A ^a   Caballero, M ^a   Mallofre, C ^a   Palacin, A ^a   Cardesa, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

34BE12; Adenosquamous carcinoma; CAM5.2; Carcinoembryonic antigen; Cytokeratin 20; Cytokeratin 7; DNA flow cytometry; Head and neck carcinoma; Immunohistochemistry; Ki67; Larynx carcinoma; Nasal carcinoma; Oral carcinoma; p53; Pharynx carcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; DNA; KI 67 ANTIGEN; PROTEIN P53;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ANEUPLOIDY; ANTIGEN EXPRESSION; ARTICLE; CARCINOMA IN SITU; CHROMOSOME 10; CHROMOSOME 12; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LARYNX; MOLECULAR WEIGHT; MOUTH CAVITY; NOSE CAVITY; PHARYNX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADULT; AGED; ANEUPLOIDY; CARCINOMA, ADENOSQUAMOUS; DNA, NEOPLASM; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 3042543550     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01881.x     Document Type: Article

References (36)

1. Hyams VJ, Batsakis JG, Michaels L. Tumors of the upper respiratory tract and ear. Atlas of tumor pathology, 2nd Series, Fascicle 25. Washington DC: Armed Forces Institute of Pathology, 1986; 104-107.
2. Damiani JM, Damiani KK, Hauch K, Hyams VJ. Mucoepidermoid-adenosquamous carcinoma of the larynx and hypopharynx: a report of 21 cases and a review of the literature. Otolaryngol. Head Neck Surg. 1981; 89; 235-243.
3. Evans HL. Mucoepidermoid carcinoma of the salivary glands: a study of 69 cases with special attention to histologic grading. Am. J. Clin. Pathol. 1984; 81; 696-701.
4. Evans HL. We have met that enemy, but it is another neoplasm. Am. J. Clin. Pathol. 1984; 82; 512-513 (Letter).
5. Shanmugaratnam K, Sobin LH. Adenosquamous carcinoma. In Histological typing of tumours of the upper respiratory tract and ear. World Health Organization, International Histological Classification of Tumours. Berlin: Springer-Verlag, 1991; 38.
6. Mills ST, Gaffey MJ, Frierson HF. Adenosquamous carcinoma. In Rosai J, Sobin LH eds. Tumors of the upper aerodigestive tract and ear. Atlas of tumor pathology, 3rd Series, Fascicle 26. Washington DC: Armed Forces Institute of Pathology, 2000; 98-106.
7. Gerughty RM, Hennigar GR, Brown FM. Adenosquamous carcinoma of the nasal, oral and laryngeal cavities. A clinicopathologic survey of ten cases. Cancer 1968; 22; 1140-1155.
8. Aden KK, Niehans G, Adams GL, Abdel-Fattah HM. Adenosquamous carcinoma of the larynx and hypopharynx with five new case presentations. Trans. Am. Laryngol. Assoc. 1988; 109; 216-221.
9. Martinez-Madrigal F, Baden E, Casiraghi O, Micheau C. Oral and pharyngeal adenosquamous carcinoma. A report of four cases with immunohistochemical studies. Eur. Arch. Otorhinolaryngol. 1991; 248; 255-258.
10. Sanderson RJ, Rivron RP, Wallace WA. Adenosquamous carcinoma of the hypopharynx. J. Laryngol. Otol. 1991; 105; 678-680.
11. Minic AJ, Stajcic Z. Adenosquamous carcinoma of the inferior turbinate: a case report. J. Oral Maxillofac. Surg. 1994; 52; 764-767.
12. Fujino K, Ito J, Kanaji M, Shiomi Y, Saiga T. Adenosquamous carcinoma of the larynx. Am. J. Otolaryngol. 1995; 16; 115-118.
13. Napier SS, Gormely JS, Newlands C, Ramsay-Baggs P. Adenosquamous carcinoma. A rare neoplasm with an aggressive course. Oral Surg. 1995; 79; 607-611.
14. Izumi K, Nakajima T, Maeda T, Cheng J, Saku T. Adenosquamous carcinoma of the tongue. Report of a case with histochemical, immunohistochemical, and ultrastructural study and review of the literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998; 85; 178-184.
15. Abdelsayed RA, Sangueza OP, Newhouse RF, Singh BS. Adenosquamous carcinoma. A case report with immunohistochemical evaluation. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998; 85; 173-177.
16. Scully C, Porter SR, Speight PM, Eveson JW, Gale D. Adenosquamous carcinoma of the mouth: a rare variant of squamous cell carcinoma. Int. J. Oral Maxillofac. Surg. 1999; 28; 125-128.
17. Keelawat S, Liu CZ, Roehm PC, Barnes L. Adenosquamous carcinoma of the upper aerodigestive tract: a clinicopathologic study of 12 cases and review of the literature. Am. J. Otolaryngol. 2002; 23; 160-168.
18. Hedley DW, Friedlander MI, Taylor LW. Method for analysis of cellular DNA content of paraffin wax-embedded pathological material using flow cytometry. J. Cytochem. Histochem. 1983; 31; 1333-1335.
19. Shankey TV, Rabinovitch PS, Bagwell B et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993; 14; 472-477.
20. Sobin LH, Wittekind C. TNM classification of malignant tumors. American Joint Committee on Cancer and International Union Against Cancer (UICC), 6th edn. New York: Wiley and Sons, 2002.
21. Hellquist H, Cardesa A, Gale N, Kambic V, Michaels L. Criteria for grading in the Lubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working Group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology. Histopathology 1999; 34; 226-233.
22. Cardesa A, Bombi JA, Pera M et al. Spectrum of glandular differentiation in experimental carcinoma of the esophagus induced by 2,6- dimethylnitrosomorpholine under the influence of esophagojejunostomy. Exp. Toxic. Pathol. 1994; 46; 41-49.
23. Foschini MP, Marucci G, Eusebi V. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Virchows Arch. 2002; 440; 536-542.
24. Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum. Pathol. 1986; 17; 1158-1166.
25. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl. Immunohistochem. 1995; 3; 99-107.
26. Chu P, Wu E, Weiss LM. Cytokeratin 7 and 20 expression in epithelial neoplasms: a survey of 435 cases. Mod. Pathol. 2000; 13; 962-972.
27. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40; 403-439.
28. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990; 17; 489-503.
29. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351; 453-456.
30. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 1992; 7; 927-933.
31. Boyle JO, Hakim J, Koch W et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993; 53; 4477-4480.
32. Nadal A, Campo E, Pinto J et al. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J. Pathol. 1995; 175; 181-188.
33. Salam MA, Crocker J, Morris A. Over-expression of tumour suppressor gene p53 in laryngeal squamous cell carcinomas and its prognostic significance. Clin. Otolaryngol. 1995; 20; 49-52.
34. Nakashima T, Wang XF, Masuda M, Inokuchi A, Komiyama S. Overexpression of p53 nuclear protein in premalignant and malignant laryngeal lesions. Eur. Arch. Otorhinolaryngol. 1999; 256 (Suppl. 1); S56-59.
35. Barlogie B, Raber MN, Schumann J. Flow cytometry in clinical cancer research. Cancer Res. 1983; 43; 3982-3997.
36. Quirke P, Dixon MF, Clayden AD et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J. Pathol. 1990; 151; 285-291.